No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: zenith trials
1
Dec 09, 2022 05:13PM

I like that share price jump from .50 to 4.54 usd.

1
Dec 10, 2022 12:31PM
1
Dec 10, 2022 01:40PM
1
Dec 23, 2022 10:38AM
1
Dec 24, 2022 01:55PM
3
Dec 25, 2022 08:57AM
Share
New Message
Please login to post a reply